SCHEMBL21137786

SCHEMBL21137786

Cc1cccc(-c2ncc(C(F)(F)F)cc2Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
NPC1 O15118 5/20 0.56
RXFP1 Q9HBX9 1/20 0.56
ALDH1A1 P00352 6/20 0.56
KDM4E B2RXH2 3/20 0.56
POLB P06746 1/20 0.56
HTT P42858 2/20 0.53
MAPT P10636 1/20 0.53
MAPK1 P28482 1/20 0.53
PKM P14618 1/20 0.52
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 2/20 0.48
LMNA P02545 1/20 0.48
AGTR1 P30556 1/20 0.48
STAT3 P40763 1/20 0.48
STAT1 P42224 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetamide SCHEMBL27527964 0.91 SMN1; SMN2 (0.51) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL28497141 0.86 NPC1 (0.52) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL18357054 0.82 RAB9A (0.58) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL21137733 0.82 ALDH1A1 (0.59) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL22783988 0.82 SMN1; SMN2 (0.53) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL22783993 0.82 NPC1 (0.53) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL6177219 0.81 ALDH1A1 (0.57) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL21137717 0.81 ALDH1A1 (0.57) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL8070658 0.80 ALDH1A1 (0.52) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1
SCHEMBL18002935 0.79 SMN1; SMN2 (0.53) RAB9ASMN1; SMN2NPC1RXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200392138-A1 PESTICIDALLY ACTIVE MESOIONIC HETEROCYCLIC COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2020-12-17 US disclosed
WO-2019115404-A1 PESTICIDALLY ACTIVE MESOIONIC HETEROCYCLIC COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2019-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392138-A1 PESTICIDALLY ACTIVE MESOIONIC HETEROCYCLIC COMPOUNDS DDT, ACHE, MNS1 RAB9A 1172/4885SMN1; SMN2 487/4885NPC1 2872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.